Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.

Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Abstract Text:

    s pichyangkulS Pichyangkul,u kum-arbU Kum-Arb,k yongvanitchitK Yongvanitchit,a limsalakpetchA Limsalakpetch,m gettayacaminM Gettayacamin,d e lanarD E Lanar,l a wareL A Ware,v a stewartV A Stewart,d g heppnerD G Heppner,p mettensP Mettens,j d cohenJ D Cohen,w r ballouW R Ballou,m m fukudaM M Fukuda,s pichyangkulS Pichyangkul,u kum-arbU Kum-Arb,k yongvanitchitK Yongvanitchit,a limsalakpetchA Limsalakpetch,m gettayacaminM Gettayacamin,d e lanarD E Lanar,l a wareL A Ware,v a stewartV A Stewart,d g heppnerD G Heppner,p mettensP Mettens,j d cohenJ D Cohen,w r ballouW R Ballou,m m fukudaM M Fukuda,s pichyangkulS Pichyangkul,u kum-arbU Kum-Arb,k yongvanitchitK Yongvanitchit,a limsalakpetchA Limsalakpetch,m gettayacaminM Gettayacamin,d e lanarD E Lanar,l a wareL A Ware,v a stewartV A Stewart,d g heppnerD G Heppner,p mettensP Mettens,j d cohenJ D Cohen,w r ballouW R Ballou,m m fukudaM M Fukuda,

    Several lines of evidence suggest that targeting pre-erythrocytic-stage parasites for malaria vaccine development can provide sterile immunity. The objectives of this study were (i) to evaluate preclinically the safety and immunogenicity of a new recombinant pre-erythrocytic-stage antigen, liver-stage antigen 1 (LSA1), in nonhuman primates; and (ii) to investigate the potential for immune interference between LSA1 and the leading malaria vaccine candidate, RTS,S, by comparing the immune responses after single-antigen vaccination to responses after simultaneous administration of both antigens at separate sites. Using a rhesus monkey model, we found that LSA1 formulated with the GlaxoSmithKline proprietary adjuvant system AS01B (LSA1/AS01B) was safe and immunogenic, inducing high titers of antigen-specific antibody and CD4+ T-cell responses, as monitored by the production of interleukin-2 and gamma interferon, using intracellular cytokine staining. RTS,S/AS01B vaccination was well tolerated and demonstrated robust antibody and moderate CD4+ T-cell responses to circumsporozoite protein (CSP) and HBsAg. Positive CD8+ T-cell responses to HBsAg were detected, whereas the responses to CSP and LSA1 were negligible. For both LSA1/AS01B and RTS,S/AS01B, no statistically significant differences were observed between individual and concurrent administration in the magnitude or duration of antibody and T-cell responses. Our results revealed that both pre-erythrocytic-stage antigens were safe and immunogenic, administered either separately or simultaneously to rhesus monkeys, and that no significant immune cross interference occurred with concurrent separate-site administration. The comparison of the profiles of immune responses induced by separate-site and single-site vaccinations with LSA1 and RTS,S warrants further investigation.

    Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Publishing Authors By Initials

    s pichyangkulS Pichyangkul,u kum-arbU Kum-Arb,k yongvanitchitK Yongvanitchit,a limsalakpetchA Limsalakpetch,m gettayacaminM Gettayacamin,de lanarDE Lanar,la wareLA Ware,va stewartVA Stewart,dg heppnerDG Heppner,p mettensP Mettens,jd cohenJD Cohen,wr ballouWR Ballou,mm fukudaMM Fukuda,s pichyangkulS Pichyangkul,u kum-arbU Kum-Arb,k yongvanitchitK Yongvanitchit,a limsalakpetchA Limsalakpetch,m gettayacaminM Gettayacamin,de lanarDE Lanar,la wareLA Ware,va stewartVA Stewart,dg heppnerDG Heppner,p mettensP Mettens,jd cohenJD Cohen,wr ballouWR Ballou,mm fukudaMM Fukuda,s pichyangkulS Pichyangkul,u kum-arbU Kum-Arb,k yongvanitchitK Yongvanitchit,a limsalakpetchA Limsalakpetch,m gettayacaminM Gettayacamin,de lanarDE Lanar,la wareLA Ware,va stewartVA Stewart,dg heppnerDG Heppner,p mettensP Mettens,jd cohenJD Cohen,wr ballouWR Ballou,mm fukudaMM Fukuda,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Infection and immunity

    VOLUME: 76

    Page Numbers: 229-38

    Journal Abbreviation:

    ISSN: 1098-5522

    DAY: 22

    MONTH: 10

    YEAR: 2007

    Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 246127

    Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.

    AFFILIATION: Department of Immunology and Medicine, USAMC-AFRIMS, 315/6 Rajvithi Rd., Bangkok 10400, Thailand. Sathitp@afrims.org

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Infect Immun

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News